If you are an individual or entity who paid any amount of money for retail purchases of Hetero Valsartan, Aurobindo Irbesartan, or Vivimed Losartan medications between January 1, 2016 and the present, you could receive a payment from class action settlements

CAMDEN, N.J., April 2, 2026 /PRNewswire/ -- The following notice is being issued by the Court approved Settlement Administrator and has been authorized by the U.S. District Court for the District of New Jersey, in In re: Valsartan, Losartan, and Irbesartan Products Liability Litigation,...